跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VENLAFAXINE GENERICHEALTH XR venlafaxine (as hydrochloride) 75mg modified release capsule blister - TGA Drug Approval Details
Approvals
/
TGA
/
VENLAFAXINE GENERICHEALTH XR venlafaxine (as hydrochloride) 75mg modified release capsule blister
Approved
STANDARD
VENLAFAXINE GENERICHEALTH XR venlafaxine (as hydrochloride) 75mg modified release capsule blister
Generic Health Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
43ecb3033bc0ff25
Company
Generic Health Pty Ltd
Type
Standard
Approval Details
Approval Id
43ecb3033bc0ff25
Product Name
VENLAFAXINE GENERICHEALTH XR venlafaxine (as hydrochloride) 75mg modified release capsule blister
Artg Id
151884
Artg Name
VENLAFAXINE GENERICHEALTH XR venlafaxine (as hydrochloride) 75mg modified release capsule blister
Sponsor
Generic Health Pty Ltd
Company Detail Path
/organization/generic-health-pty-ltd
Artg Date
2009-08-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5949fe5312eb55a71a55305a33351b6d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3182f302784854c89a37442ff2a903d4.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
43ecb3033bc0ff25
Type
Standard
Back to TGA Approvals